Carlos A. Zarate
National Institutes of Health(US)University of California, San Francisco(US)Intarcia Therapeutics (United States)(US)National Institute of Health(AM)National Institute of Mental Health(US)National Institute of Mental Health(CZ)The University of Texas Health Science Center at Houston(US)Stanford University(US)
Publications by Year
Research Areas
Treatment of Major Depression, Tryptophan and brain disorders, Bipolar Disorder and Treatment, Functional Brain Connectivity Studies, Mental Health Research Topics
Most-Cited Works
- → A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression(2006)3,706 cited
- → NMDAR inhibition-independent antidepressant actions of ketamine metabolites(2016)1,565 cited
- → Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms(2018)1,216 cited
- → Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors(2007)1,097 cited
- → A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression(2010)958 cited
- → Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders(2008)882 cited